Ulna Fractures Clinical Trial
— DUL-ITSOfficial title:
Prospective Case Series to Assess the Handling, Healing and Complications of Using a Titanium Small Fragment Plating System With a New Shape Specifically Adapted to the Distal Ulna
NCT number | NCT05329012 |
Other study ID # | DUL - ITS |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | August 1, 2010 |
Est. completion date | August 30, 2016 |
Verified date | April 2022 |
Source | Medical University Innsbruck |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Background of the study: Various studies show that the outcome of unstable distal ulna fractures after open reduction and internal fixation is better than closed reduction. The previous plate system for the distal ulna fractures is applied exclusively on the extensor side. This often leads to irritation of the extensor tendons, as well as problems with pronation and supination. With the new shape of the angle-stable distal ulna plate, the investigator hopes that the stability of the fracture osteosynthesis will remain the same and that it will be better tolerated with regard to the surrounding soft tissue, especially the extensor tendons. In this way, an otherwise practically unavoidable removal of osteosynthesis material could - at least in some cases - be avoided and some patients spared a follow-up operation. With this in mind, the investigator tries to achieve the greatest possible reconstruction and stability for early functional follow-up treatment with a slightly bulky implant placed in the tendon-free area.
Status | Completed |
Enrollment | 22 |
Est. completion date | August 30, 2016 |
Est. primary completion date | August 30, 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Age over 18 years 2. unstable distal ulna fractures Fracture classification according to Biyani [4]: all types Exclusion Criteria: 1. Age under 18 years old 2. stable fractures of the ulna 3. Patient had one before ulna fracture 4. Patient may result in physical or intellectual disability consent not grant 5. Patient is for more Check-ups not available (Abroad) 6. Patient does not have full legal capacity 7. Alcohol and drug abuse 8. Increased risk of anesthesia (from ASA 3) |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Medical University Innsbruck |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Complicationsrate | Percentage of complications rate of patients treated with DUL | 1 year | |
Secondary | Clinical outcome (range of motion) | Degree of the possible range of motion using a goniometer to measure the movement angles in correlation of the healing process. The better the range of motion the higher the value. Normally the following limits are given:
Radial: least 0 degree, maximum: 20 degree Ulnar: least 0 degree, maximum: 40 degree Extension: least 0 degree, maximum: 70 degree Flexion: least 0 degree, maximum: 70 degree Pronation: least 0 degree, maximum: 90 degree Supination: least 0 degree, maximum: 90 degree |
1year | |
Secondary | Clinical outcome (grip strength wrist) | Extent of possible grip strength measurement using dynanometer in correlation of the healing process.
Minimum: 0 kilogram Maximum: 80 kg |
1year | |
Secondary | Patient Reported Outcome (function) | Percentage of the patients with reduced or normal outcome after fractures using questionnaires like the DASH Score in correlation of the healing process. This is a score reporting the functional outcome, satisfaction and quality of life. Best score is 100%, least score 0% | 1 year | |
Secondary | Patient Reported Outcome (pain) | Percentage of the patients with remaining pain after fracture using the visual analog scale in correlation of the healing process.
The scale reports about the intensity of pain. The maximum pain and least score is 10, and the best score is 0 which means "no pain". |
1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02630290 -
Addition of Dexmedetomidine to Ropivacaine-induced Supraclavicular Block (ADRIB Trial)
|
Phase 4 | |
Not yet recruiting |
NCT06304649 -
Clinical Evaluation of Cast21 Short Arm Product During Treatment of Distal Radial or Distal Ulnar Fractures
|
N/A |